written by reader The Most Valuable Pill in the World will double your money

By saint stephen, July 17, 2018

Stansberry research is touting a biotech pick that will cure a disease that kills 1 out of 4 people. What is it?

This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.



This site uses Akismet to reduce spam. Learn how your comment data is processed.

Inline Feedbacks
View all comments
July 18, 2018 3:33 pm

I was trying to figure this out myself, after doing a little research i think the ticker is ESPR.. @ $43/Share roughly…. The disease is heart disease, but their medicine targets high cholesterol, which I am guessing is a contributing factor to heart disease? Let me know what you guys think!

Add a Topic
Travis Johnson, Stock Gumshoe
July 25, 2018 10:35 am
Reply to  Bunchy

I think you’re right, we covered that one here: https://www.stockgumshoe.com/reviews/stansberry-venture/stansberry-ventures-most-valuable-pill-in-development-anywhere-pitch/

Add a Topic
Add a Topic
Add a Topic
👍 16184

We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

More Info